This update is based on a press release statement from Invivyd, Inc. The company's stock has experienced significant volatility, with a 16.39% gain in the past week despite a 64.17% decline over six ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

A study suggests that catching COVID-19 significantly raises the risk of developing ME/CFS (formerly called "chronic fatigue ...

The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...

Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

The Health Department of Northwest Michigan is reporting an increase in respiratory illnesses across Antrim, Charlevoix, ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

An Exeter-based research firm has developed what it believes is a "world first" breakthrough test to help confirm the ...